Enocef 500 mg/vial (IV Injection)
500 mg vial: ৳ 150.57
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Synovia pharma plc |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- Broad-spectrum parenteral cephalosporin antibiotic
- Potent bactericidal activity
- Interference with the synthesis of bacterial cell wall
- Long plasma elimination half-life of 6 to 9 hours
- High stability in the presence of beta lactamases
- No metabolism in the body
- Up to 65% excretion in urine
- High protein binding of 95%
Dosage
- Usual adult dose of 1 to 2 gm by intravenous or intramuscular administration once a day
- Maximum adult dose of 4 gm/day
- Different dosage for uncomplicated gonococcal infections and surgical prophylaxis
- Usual dose for infants and children (01 month or older) is 50 to 75 mg/kg intravenously or intramuscularly once a day
- Duration of therapy usually 4 to 14 days
Administration
- Preparation of solutions for intramuscular / intravenous injections
- Instructions for intramuscular and intravenous injections
- Administration over 2-4 minutes for injections
- Reconstituted solution potency maintenance for at least 6 hours at room temperature or 24 hours at 5°C
Interaction
- No reported drug interactions
Contraindications
- Not to be given to patients with history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea and vomiting, stomatitis and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness
- Rare occurrence of local phlebitis
Pregnancy & Lactation
- No established safety in human pregnancy
- Caution required when administered to lactating mothers
Precautions & Warnings
- Potential for anaphylactic shock
- Monitoring of blood picture during prolonged treatment
Use in Special Populations
- Avoid use in neonates if premature or newborn up to 28 days of age
Overdose Effects
- No specific antidote
- Treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Vial should be stored in a cool, dry place (below 30°C), away from light and moisture
- Keep out of the reach of children